We conclude that neither glucagon nor GLP-1 affect the lipolysis rate of human sc adipose tissue or skeletal muscle.

Human SCs were co-cultivated with NB tumours and cell lines, and were harvested after defined time intervals.

These human SCs are label-retaining cells and are capable of self-renewal through asymmetric cell division in vitro.

Here we report the first long-term glycemic correction of a diabetic, immunocompetent animal model using human SC-β cells.

More specifically, to implement an intravoxel incoherent motion (IVIM) protocol at ultrahigh field for the human SC and assess parameters estimation errors.